Back to Search
Start Over
Effects of meditation compared to music listening on biomarkers in breast cancer survivors with cognitive complaints: secondary outcomes of a pilot randomized control trial
- Source :
- EXPLORE. 18:657-662
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
-
Abstract
- Context: We previously reported positive behavioral effects of both daily mantra meditation and classical music listening interventions in breast cancer survivors with cancer related cognitive complaints. Objective: The objective of this pilot study was to compare the effects of the meditation intervention to a music listening intervention on biomarkers of inflammation and cellular aging (secondary outcomes) in breast cancer survivors. Design: Randomized control trial, baseline data collection (time 1), post intervention data collection (time 2) Setting: Community-based, Central Texas Participants: 25 breast cancer survivors (BCS) who were 3 months to 6 years post chemotherapy completion and reported cognitive decline Intervention(s): Kirtan Kriya meditation (KK) or music listening (ML), 8 weeks, 12 minutes a day Main Outcome: Telomerase activity [TA], c-reactive protein [CRP], soluble IL-2 receptor alpha [sIL-2Rα], soluble IL-4 receptor [sIL-4R], soluble IL-6 receptor [sIL-6R], soluble tumor necrosis factor receptor II [sTNF-RII], VEGF receptor 2 [sVEGF-R2], and VEGF receptor 3 [sVEGF-R3] Results: Repeated measures analysis of variance models were analyzed from time 1 to time 2 by group for each biomarker. A pattern of greater telomerase activity across time in both groups (F (1,15) = 3.98, p = .06, η²p = .21); significant decreases in sIL-4R across time for both groups (F (1,22)= 6.28, p = .02, η²p = .22); group*time effect was nominally different but not statistically different for sIL-4R (F(1,22)= 3.82, p = .06, η²p = .15); and a pattern for a group*time effect with ML group showing higher levels of sVEGF-R3 at time 2 (F (1,20)=, p = .12, η²p = .11). No significant effects were found for CRP, sIL-2Rα, sIL-6R, sTNF-RII, or sVEGF-R2.
- Subjects :
- Oncology
medicine.medical_specialty
media_common.quotation_subject
Pilot Projects
Breast Neoplasms
Context (language use)
law.invention
Cognition
Breast cancer
Cancer Survivors
Randomized controlled trial
law
Internal medicine
medicine
Humans
Meditation
Cognitive decline
Telomerase
General Nursing
media_common
business.industry
Cancer
Repeated measures design
medicine.disease
C-Reactive Protein
Receptors, Vascular Endothelial Growth Factor
Complementary and alternative medicine
Biomarker (medicine)
Female
Chiropractics
business
Music
Biomarkers
Analysis
Subjects
Details
- ISSN :
- 15508307
- Volume :
- 18
- Database :
- OpenAIRE
- Journal :
- EXPLORE
- Accession number :
- edsair.doi.dedup.....b256b787964df5245f88be7e8822dd6e